Ultrasound‐Mediated Thrombolysis: From Mechanistic Insights to Advanced Nanoplatforms and Clinical Translation
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71296 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Chu Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Imaging, Xuzhou Medical University, Xuzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Thrombolytic Therapy, Ultrasonic Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Hunan Provincial Key Research and Development Program, National Natural Science Foundation of China, Science and Technology Program of Xuzhou.
Abstract (Originalsprache)
Although pharmacological thrombolysis and mechanical thrombectomy are standard treatments for thromboembolic diseases, they are limited by hemorrhagic risks and incomplete revascularization. Ultrasound‐mediated thrombolysis (UMT) has emerged as a promising targeted therapy that leverages acoustic cavitation and microstreaming to overcome these limitations. This review elucidates the core biophysical mechanisms of UMT, highlighting how acoustic forces synergize with fibrinolytic agents to enhance drug penetration and disrupt clot architecture. We categorize current technologies ranging from Food and Drug Administration (FDA)‐approved catheter‐directed systems (e.g., EkoSonic system) to emerging non‐invasive histotripsy and stimuli‐responsive nanoplatforms, with an emphasis on recent advances in materials‐enabled ultrasound therapies. Furthermore, the integration of multimodal imaging and artificial intelligence is discussed as a pathway toward precision closed‐loop therapy. By identifying key translational barriers—including challenges in nanoplatform design, cavitation control, and biosafety—this review proposes a paradigm shift from acute recanalization to integrated thrombo‐inflammatory management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Imaging, Xuzhou Medical University, Xuzhou, Jiangsu, China.
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, China.
- Jiangsu Medical Imaging and Digital Medical Engineering Research Center, Xuzhou, Jiangsu, China.
ORCID-Profile: Zhenbao Liu
Förderung
- Hunan Provincial Key Research and Development Program
- National Natural Science Foundation of China
- Science and Technology Program of Xuzhou
- China Postdoctoral Science Foundation
- Postdoctoral Research Funding Program of Jiangsu Province
- Jiangsu Training Program of Innovation and Entrepreneurship for Undergraduates
Zitieren
APA
Wu, C., Cui, H., Yan, X., Tang, Y., Wu, R., Qiang, R., Wu, Y., Pan, X., Lin, Q., Liu, Z., & Shi, M. (2026). Ultrasound‐Mediated Thrombolysis: From Mechanistic Insights to Advanced Nanoplatforms and Clinical Translation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71296
Vancouver
Wu C, Cui H, Yan X, Tang Y, Wu R, Qiang R, et al. Ultrasound‐Mediated Thrombolysis: From Mechanistic Insights to Advanced Nanoplatforms and Clinical Translation. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71296
BibTeX
@article{Wu2026,
author = {Wu, Chu and Cui, Hao and Yan, Xinyu and Tang, Yue and Wu, Ruotong and Qiang, Ruihan and Wu, Yao and Pan, Xingqi and Lin, Qunxiang and Liu, Zhenbao and Shi, Meilin},
title = {Ultrasound‐Mediated Thrombolysis: From Mechanistic Insights to Advanced Nanoplatforms and Clinical Translation},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71296}
}
EUVIMED